CBC Group

Recently, we successfully concluded our 2024 Annual General Meeting in Singapore, where we had the privilege of hosting over 100 investors and partners from around the world, while celebrating a significant milestone-our 10th Anniversary. During the event, our CEO, Wei Fu, delivered an inspiring opening address, reflecting on CBC's journey and achievements over the past decade. With a steadfast focus on value investment, CBC Group has navigated its own course to thrive and grow amid market cycles. The event featured engaging panel discussions led by our leadership team and portfolio executives, igniting vibrant conversations about market opportunities and strategic initiatives for the future. As we usher in the next decade, we remain committed to the fundamentals and creating value and generating alpha for our investors and shareholders through our multi-product strategies- Private Equity, Private Credit, and Real Assets-to realize our shared vision of Better Healthcare for All, shaping the industry's future, and creating lasting impact. #AGM #BetterHealthcareforAll #PortfolioEcosystem #OneCBC

We are thrilled to announce the appointment of Ed Li as Chief Operating Officer of CBC Group. In addition to his current position as COO and General Counsel of the CBC Healthcare Infrastructure Platform, Edward will now spearhead our operational strategy across the firm.   With over 26 years of experience in M&A, legal, and management, Edward brings a wealth of expertise that will be pivotal in strengthening our operational framework. His leadership will enhance efficiency, drive innovation, and foster cross-functional collaboration globally, while supporting our strategic growth initiatives and improving organizational effectiveness, ultimately positioning the firm for future success.   Please join us in congratulating Edward on his new role!   #Leadership #OneCBC #ExecutiveTeam #BetterHealthcareforAll

We're 10! For a decade, we've been driving healthcare innovation and creating value, guided by our vision of "Better Healthcare for All." Our journey has been remarkable:  • Introduced 40+ innovative R&D pipelines to China  • Built a workforce of 10,000+ across our portfolio companies A heartfelt thank you to our investors, partners, and CBCers who have supported us along this extraordinary journey. Here's to another decade of groundbreaking innovation, lasting impact, and shared dreams! #10thAnniversary #BetterHealthcareforAll #Momentum #OneCBC 

We’re #hiring a new Fund Tax Manager (Singapore) in Singapore. Apply today or share this post with your network.

We’re #hiring a new Administrative Assistant and Concierge Ambassador (Singapore) in Singapore. Apply today or share this post with your network.

Recently, we hosted a series of insightful “Learn Over Lunch” sessions where CBCers shared knowledge on ESG, GP-Led Secondaries, and Middle East Market Overview, sparked engaging discussions and fostered a culture of continuous learning.   From caring initiatives to creative workshops, CBC Group is committed in creating a positive and inclusive work environment that nurtures a collaborative culture, positioning us for long-term success.   At the end of the day, our people form the cornerstone of our success!   #LearningAndGrowth #CultureBuilding #PeopleAndCulture #TeamCollaboration #OneCBC

We are pleased to share that CBC Healthcare Infrastructure Platform (CBC HIP) recently earned Gold Certification in LEED v4.1 O+M: EB for all 17 R&D, manufacturing, and office buildings within the CBC Life Science Park, Daxing Beijing, making it the first life science real assets cluster in China to achieve this certification.   Edward Li, Managing Director of CBC Group and Chief Operating Officer of CBC HIP said, “CBC HIP is proud to have received this certification and I am excited about CBC HIP's goal of becoming the leading ESG performer in the life science infrastructure sector, providing environmentally friendly and socially responsible R&D and manufacturing facilities for life science enterprises. Through assets managed by CBC HIP, we aim to attract top scientists, entrepreneurs, and business leaders in the life science sectors to foster technical innovation and breakthroughs. We are committed to contributing positively to environmental protection, low-carbon development, and achieving China's 30-60 carbon neutrality target."   Read more: https://lnkd.in/g_2EZYRb   #LEEDinChina #Greenbuildings #Sustainabledevelopment 

We’re excited to share that in partnership with Mubadala, the Abu Dhabi based global investment company, we have acquired 100% ownership in the carve-out of global biopharmaceutical company UCB Pharma’s mature business in China. The scope of this acquisition includes UCB’s neurology portfolio (Keppra®, Vimpat®, Neupro®) and allergy portfolio (Zyrtec®, Xyzal®) in Mainland China, as well as UCB’s Zhuhai manufacturing site.    The transaction remains subject to certain closing conditions, including required anti-trust clearance(s) and other customary conditions, and is expected to close in Q4 2024. #InvestorOperator #Buyout #CNSBiopharmaPlatform

At the 2024 Global Perspective panel titled “How Decision-Makers Perceive the Chinese Healthcare Market”, Annie Lee, our Senior Managing Director, Private Equity & Head of Pharma, shared her views on the evolving opportunities within the current challenging market, highlighting key trends, investment strategies, and the potential impact of emerging advancements on the future growth of the healthcare industry. “By leveraging China’s existing resources, manufacturing, and R&D capabilities, it is possible to effectively bring innovative products from China to the global market. This has been a distinctive operating model of CBC Group over the past years. I am confident that through the combination of private capital and pharma MNCs, we can support their business transformation in China and ensure that these high-quality products become more affordable and accessible to a broader group of patients across Asia and beyond, thus driving the growth of the healthcare industry and creating long-lasting value globally.” #CBCModel #ValueCreation #BetterHealthcareforAll #GlobalMarket

At Everest Medicines’s recent All-Hands gathering, Wei Fu, CEO of CBC Group and Chairman of Everest Medicines (“Everest”), delivered inspiring opening remarks to all staff and shared his deep appreciation for the team’s dedication and hard work as Everest Medicine stands at a pivotal moment in its transformation into a leading biopharma company.  “I am confident that Everest will reach new heights”, said Fu Wei, “We are committed to delivering medicines to patients through our commercialization efforts, making better healthcare accessible to all.” Founded in 2017 and listed on the Hong Kong Stock Exchange in 2020, Everest is a biopharmaceutical company incubated by CBC Group, focused on discovering, developing, manufacturing, and commercializing transformative pharmaceutical products and vaccines. With CBC’s unique “Investor-Operator” approach, Everest is now entering a fast-growing stage of commercialization. #BetterHealthcareForAll #Efficiency #Focus